Embecta Corp (NASDAQ: EMBC) has a higher price-to-earnings ratio of 11.59x compared to its average ratio, The 36-month beta value for EMBC is at 1.18. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for EMBC is 54.39M, and currently, shorts hold a 5.40% of that float. The average trading volume for EMBC on May 23, 2025 was 608.09K shares.
EMBC) stock’s latest price update
The stock of Embecta Corp (NASDAQ: EMBC) has decreased by -14.97 when compared to last closing price of 12.35. Despite this, the company has experienced a -9.91% fall in its stock price over the last five trading sessions. globenewswire.com reported 2025-05-22 that PARSIPPANY, N.J., May 22, 2025 (GLOBE NEWSWIRE) — Embecta Corp. (“embecta”; “The Company”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host its inaugural Analyst and Investor Day today to showcase its phased approach for value creation and present its long range financial plan (“LRP”).
EMBC’s Market Performance
EMBC’s stock has fallen by -9.91% in the past week, with a monthly drop of -6.54% and a quarterly drop of -25.50%. The volatility ratio for the week is 9.33% while the volatility levels for the last 30 days are 5.56% for Embecta Corp The simple moving average for the last 20 days is -13.65% for EMBC stock, with a simple moving average of -30.87% for the last 200 days.
Analysts’ Opinion of EMBC
Many brokerage firms have already submitted their reports for EMBC stocks, with Mizuho repeating the rating for EMBC by listing it as a “Neutral.” The predicted price for EMBC in the upcoming period, according to Mizuho is $15 based on the research report published on April 10, 2025 of the current year 2025.
Morgan Stanley, on the other hand, stated in their research note that they expect to see EMBC reach a price target of $20, previously predicting the price at $13. The rating they have provided for EMBC stocks is “Equal-Weight” according to the report published on December 02nd, 2024.
BTIG Research gave a rating of “Buy” to EMBC, setting the target price at $26 in the report published on November 27th of the previous year.
EMBC Trading at -14.37% from the 50-Day Moving Average
After a stumble in the market that brought EMBC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -51.09% of loss for the given period.
Volatility was left at 5.56%, however, over the last 30 days, the volatility rate increased by 9.33%, as shares sank -10.60% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -22.24% lower at present.
During the last 5 trading sessions, EMBC fell by -9.91%, which changed the moving average for the period of 200-days by -25.71% in comparison to the 20-day moving average, which settled at $12.17. In addition, Embecta Corp saw -49.13% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EMBC starting from Melcher David F, who purchase 13,000 shares at the price of $13.67 back on Feb 25 ’25. After this action, Melcher David F now owns 76,681 shares of Embecta Corp, valued at $177,646 using the latest closing price.
Morris Milton Mayo, the Director of Embecta Corp, sale 3,100 shares at $16.38 during a trade that took place back on Feb 13 ’25, which means that Morris Milton Mayo is holding 36,133 shares at $50,783 based on the most recent closing price.
Stock Fundamentals for EMBC
Current profitability levels for the company are sitting at:
- 0.16 for the present operating margin
- 0.63 for the gross margin
The net margin for Embecta Corp stands at 0.05. The total capital return value is set at 0.2.
Based on Embecta Corp (EMBC), the company’s capital structure generated 1.9 points at debt to capital in total, while cash flow to debt ratio is standing at 0.03. The debt to equity ratio resting at -2.11. The interest coverage ratio of the stock is 2.99.
Currently, EBITDA for the company is 199.0 million with net debt to EBITDA at 6.65. When we switch over and look at the enterprise to sales, we see a ratio of 1.81. The receivables turnover for the company is 5.82for trailing twelve months and the total asset turnover is 0.96. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.48.
Conclusion
In conclusion, Embecta Corp (EMBC) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
